---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-042288"
form_type: "8-K"
ticker: "ITRMF"
cik: "0001659323"
company_name: "Iterum Therapeutics plc"
filed_at: "2024-04-05T23:59:59+00:00"
generated_at: "2026-06-04T01:50:40.308051+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Iterum Therapeutics receives Nasdaq delisting notice for equity deficit of $6.4M

## Summary
- Stockholders' equity deficit of $6.4M as of Dec 31, 2023, below Nasdaq's $2.5M minimum.
- Company must submit a compliance plan by May 20, 2024; Nasdaq may extend deadline to Sept 30, 2024.
- If plan is rejected or compliance not regained, delisting proceedings may begin with appeal rights.
- Iterum is evaluating options to resolve the deficiency; listing continues for now.

## SEC filing metadata
- accession: 0000950170-24-042288
- form_type: 8-K
- ticker: ITRMF
- cik: 0001659323
- company_name: Iterum Therapeutics plc
- filed_at: 2024-04-05T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1659323/000095017024042288/0000950170-24-042288-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1659323/000095017024042288/itrm-20240403.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-042288
- JSON: https://secwatch.observer/filing/0000950170-24-042288.json
- Plain text: https://secwatch.observer/filing/0000950170-24-042288.txt

## Key facts
- Listing & Compliance Notices
  Iterum Therapeutics plc received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: stockholders equity
  - Rules: 5550(b)(1)
  source text: April 3, 2024, Iterum Therapeutics plc (the “Company”) received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), because (i) the stockholders’ equity (deficit) of the Company of ($6,403,000) as of December 31, 2023, as reported in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, was below the minimum stockholders’ equity requirement of $2,500,000 and (ii) the Company did not, as of April 3, 2024, meet the alternatives standards of market value of listed securities or net income from c
  evidence_url: https://www.sec.gov/Archives/edgar/data/1659323/000095017024042288/0000950170-24-042288-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.